title: Meeting the challenge of recurrent Clostridium difficile infection.
abstract: Recurrent Clostridium difficile infection (CDI) is a growing problem that poses significant management challenges. There is no strong evidence to support a particular treatment strategy for recurrent CDI, especially those with multiple recurrences. However, a key strategy for reducing recurrent CDI is prompt diagnosis and treatment, facilitated by early recognition of patients at risk for recurrence.
authors.affiliation: Division of Infectious Diseases, Department of Medicine, Loyola University Medical School, Maywood, Illinois 60153, USA. sjohnson@lumc.edu
authors.forename: Stuart
authors.initials: S
authors.lastname: Johnson
mesh_terms: D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016360:Clostridioides difficile / Q000302:isolation & purification / Q000472:pathogenicity; D004761:Enterocolitis, Pseudomembranous / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control; D005260:Female; D005440:Fluid Therapy; D006801:Humans; D006920:Hygiene / Q000193:education / Q000592:standards; D008795:Metronidazole / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012307:Risk Factors; D055502:Secondary Prevention; D012720:Severity of Illness Index; D014640:Vancomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D008795:Metronidazole; D014640:Vancomycin